Skip to main content

Advertisement

Log in

Glutathione S-transferase (GSTM1, GSTT1 and GSTA1) polymorphisms and outcomes after treatment for acute myeloid leukemia: pharmacogenetics in Southwest Oncology Group (SWOG) clinical trials

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Joel SP, Rohatiner A . Pharmacology of antileukemic drugs. In: Henderson ES, Lister TA, Greaves MF (eds). Leukemia, Saunders: Philadelphia, PA, 2002, pp 394–440.

    Google Scholar 

  2. Hayes JD, McLellan LI . Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999; 31: 273–300.

    Article  CAS  PubMed  Google Scholar 

  3. Ambrosone CB, Tian C, Ahn J, Kropp S, Helmbold I, von Fournier D et al. Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study. Breast Cancer Res 2006; 8: R40.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen IM et al. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood 1997; 89: 3323–3329.

    CAS  PubMed  Google Scholar 

  5. Autrup JL, Hokland P, Pedersen L, Autrup H . Effect of glutathione S-transferases on the survival of patients with acute myeloid leukaemia. Eur J Pharmacol 2002; 438: 15–18.

    Article  CAS  PubMed  Google Scholar 

  6. Voso MT, D'Alo F, Putzulu R, Mele L, Scardocci A, Chiusolo P et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood 2002; 100: 2703–2707.

    Article  CAS  PubMed  Google Scholar 

  7. Naoe T, Tagawa Y, Kiyoi H, Kodera Y, Miyawaki S, Asou N et al. Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy. Leukemia 2002; 16: 203–208.

    Article  CAS  PubMed  Google Scholar 

  8. Davies SM, Robison LL, Buckley JD, Tjoa T, Woods WG, Radloff GA et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol 2001; 19: 1279–1287.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This investigation was supported in part by the following PHS Cooperative Agreement Grant numbers awarded by the National Cancer Institute, DHHS: CA38926, CA32102, and from a grant from the Southwest Oncology Group Hope Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C B Ambrosone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weiss, J., Kopecky, K., Godwin, J. et al. Glutathione S-transferase (GSTM1, GSTT1 and GSTA1) polymorphisms and outcomes after treatment for acute myeloid leukemia: pharmacogenetics in Southwest Oncology Group (SWOG) clinical trials. Leukemia 20, 2169–2171 (2006). https://doi.org/10.1038/sj.leu.2404421

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404421

  • Springer Nature Limited

This article is cited by

Navigation